EAM

Exome Asset Management Portfolio holdings

AUM $170M
1-Year Est. Return 208.51%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+208.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$170M
AUM Growth
-$32.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1
+$4.1M
2
+$3.95M
3
+$3.91M
4
BSX icon
Boston Scientific
BSX
+$3.87M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$3.57M

Top Sells

1
+$5.49M
2
+$5.26M
3
+$4.5M
4
IMVT icon
Immunovant
IMVT
+$4.03M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$3.91M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
51
Centessa Pharmaceuticals
CNTA
$6.13B
– –
0
DXCM icon
52
DexCom
DXCM
$28.1B
– –
-50,147
KPTI icon
53
Karyopharm Therapeutics
KPTI
$206M
– –
-295,541
PGEN icon
54
Precigen
PGEN
$1.28B
– –
0
RARE icon
55
Ultragenyx Pharmaceutical
RARE
$2.16B
– –
0
RAPT
56
DELISTED
RAPT Therapeutics
RAPT
– –
-14,194
THC icon
57
Tenet Healthcare
THC
$14B
– –
-6,084
TVTX icon
58
Travere Therapeutics
TVTX
$4.26B
– –
-89,052
UHS icon
59
Universal Health Services
UHS
$8.79B
– –
-17,628
WVE icon
60
Wave Life Sciences
WVE
$1.1B
– –
-421,488
XBI icon
61
State Street SPDR S&P Biotech ETF
XBI
$7.83B
– –
0
WAY
62
Waystar Holding Corp
WAY
$3.84B
– –
-68,969
UPB
63
Upstream Bio Inc
UPB
$384M
– –
-64,845
ONC
64
BeOne Medicines Ltd
ONC
$28B
– –
0
EWTX icon
65
Edgewise Therapeutics
EWTX
$3.83B
– –
-100,046
FULC icon
66
Fulcrum Therapeutics
FULC
$246M
– –
-92,055
GOSS icon
67
Gossamer Bio
GOSS
$41.1M
– –
-451,699
IDYA icon
68
IDEAYA Biosciences
IDYA
$2.49B
– –
0
IKT icon
69
Inhibikase Therapeutics
IKT
$215M
– –
-600,000
IMCR icon
70
Immunocore
IMCR
$1.44B
– –
-76,750
IMVT icon
71
Immunovant
IMVT
$6.39B
– –
-158,622
IQV icon
72
IQVIA
IQV
$30.6B
– –
-5,378
IRON icon
73
Disc Medicine
IRON
$2.56B
– –
-46,743
IRWD icon
74
Ironwood Pharmaceuticals
IRWD
$545M
– –
-648,532
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$15B
– –
-26,494
1 2
3